Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Biomarin Pharmaceut (BMRN)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 14,688,933
  • Shares Outstanding, K 178,372
  • Annual Sales, $ 1,491 M
  • Annual Income, $ -77,210 K
  • 60-Month Beta 1.51
  • Price/Sales 10.59
  • Price/Cash Flow 413.45
  • Price/Book 5.31

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 20 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/19
See More
  • Average Estimate -0.12
  • Number of Estimates 7
  • High Estimate -0.01
  • Low Estimate -0.24
  • Prior Year -0.08
  • Growth Rate Est. (year over year) -50.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
81.22 +2.39%
on 04/18/19
94.00 -11.53%
on 04/05/19
-10.20 (-10.93%)
since 03/18/19
3-Month
81.22 +2.39%
on 04/18/19
100.13 -16.95%
on 02/05/19
-14.53 (-14.87%)
since 01/18/19
52-Week
79.13 +5.09%
on 12/26/18
106.74 -22.09%
on 10/17/18
-1.26 (-1.49%)
since 04/18/18

Most Recent Stories

More News
Biomarin Pharmac Falls 5.23% on Heavy Volume: Watch For Potential Rebound

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $83.88 to a high of $87.86. Yesterday, the shares fell 5.2%, which took the trading range below the 3-day low of...

BMRN : 83.16 (+0.98%)
Forbes Names BioMarin 4th Best Midsize Employer in America

BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced today that it has been ranked fourth on Forbes magazine's 2019 list of "America's Best Midsize Employers," increasing from 51st on last year's 2018...

BMRN : 83.16 (+0.98%)
New Strong Sell Stocks for April 16th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today

ALK : 61.67 (+0.47%)
CCRN : 7.02 (+0.86%)
BMRN : 83.16 (+0.98%)
EXTN : 17.06 (-1.22%)
CSBR : 7.90 (+5.19%)
Look for Shares of Biomarin Pharmac to Potentially Rebound after Yesterday's 2.62% Sell Off

Biomarin Pharmac (NASDAQ:BMRN) traded in a range yesterday that spanned from a low of $89.75 to a high of $92.30. Yesterday, the shares fell 2.6%, which took the trading range below the 3-day low of...

BMRN : 83.16 (+0.98%)
New Research Coverage Highlights BioMarin Pharmaceutical, EnLink Midstream, GCI Liberty, Vistra Energy, BioTime, and Karyopharm Therapeutics -- Consolidated Revenues, Company Growth, and Expectations for 2019

In new independent research reports released early this morning, Capital Review released its latest key findings for all current investors, traders, and shareholders of BioMarin Pharmaceutical Inc. (NASDAQ:BMRN),...

ENLC : 12.10 (-1.39%)
VST : 26.01 (+1.32%)
BTX : 1.25 (+4.17%)
BMRN : 83.16 (+0.98%)
KPTI : 4.63 (-3.94%)
GLIBA : 58.53 (+0.05%)
BioMarin to Host First Quarter 2019 Financial Results Conference Call and Webcast on Thursday, April 25 at 4:30pm ET

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer of BioMarin, will host a conference call and webcast on Thursday, April 25,...

BMRN : 83.16 (+0.98%)
New Strong Sell Stocks for March 29th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today.

BMRN : 83.16 (+0.98%)
CZR : 9.56 (+0.95%)
ALV : 86.75 (+1.46%)
AVP : 2.64 (-1.49%)
VNET : 7.76 (-2.76%)
Sarepta (SRPT) Reports Positive Interim Results for DMD Drug

Sarepta???s (SRPT) key pipeline candidate leads to statistically significant increase in dystrophin production in ESSENCE study. NDA to be filed mid-2019.

CATB : 8.10 (-1.22%)
SRPT : 116.64 (-1.76%)
BMRN : 83.16 (+0.98%)
PFE : 39.38 (-1.25%)
New Strong Sell Stocks for March 27th

Here are 5 stocks added to the Zacks Rank #5 (Strong Sell) List today:

BUD : 89.96 (+1.85%)
AEIS : 57.52 (+1.13%)
BMRN : 83.16 (+0.98%)
CSBR : 7.90 (+5.19%)
ASIX : 30.33 (-0.59%)
S&P Fights Past Growth Concerns to Reclaim 2800

S&P Fights Past Growth Concerns to Reclaim 2800

WAGE : 40.00 (-0.62%)
MIME : 47.53 (-3.26%)
SVMK : 17.48 (+0.58%)
BMRN : 83.16 (+0.98%)
SLB : 45.56 (-3.90%)
IONS : 72.99 (+0.44%)
AZUL : 25.88 (+7.03%)
OLLI : 92.77 (+0.05%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade BMRN with:

Business Summary

BioMarin Pharmaceutical Inc. is a developer of carbohydrate enzyme therapies for debilitating, life-threatening, chronic genetic disorders and other diseases and conditions. The company completed a six-month evaluation of patients being treated with BioMarin's lead product, BM101, for the treatment...

See More

Key Turning Points

2nd Resistance Point 86.20
1st Resistance Point 84.68
Last Price 83.16
1st Support Level 81.43
2nd Support Level 79.70

See More

52-Week High 106.74
Fibonacci 61.8% 96.19
Fibonacci 50% 92.93
Fibonacci 38.2% 89.68
Last Price 83.16
52-Week Low 79.13

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar